44
Participants
Start Date
June 30, 2010
Primary Completion Date
August 31, 2012
Study Completion Date
August 31, 2012
Zoledronic acid
Patients with no bone metastasis (n=150) will receive Standard therapy plus Zoledronic acid administration 4 mg IV monthly during Months 1-18.
Standard Therapy
Standard Therapy, including chemotherapy and hormonal therapy, was determined at the discretion of the investigator.
NYU Langone Arena Oncology, Lake Success
Milton S Hershey Medical Center Hershey Medical Center (4), Hershey
Abington Hematology Oncology Associates, Inc, Willow Grove
Berks Hematology Oncology, West Reading
Medical Oncology & Hematology Associates of Northern VA Med. Onc&Hem Assoc. of No.VA, Reston
Piedmont Hematology and Oncology Associates Piedmont Hem/Onc Assoc (2), Winston-Salem
Marion L. Shepard Cancer Center, Washington
Space Coast Medical Associates, Titusville
Lakeland Regional Cancer Center Dept. of Lakeland Regional, Lakeland
Florida Cancer Specialists DeptofFloridaCancerSpecialists, Fort Myers
Sarah Cannon Research Institute, Nashville
The West Clinic, Memphis
Hematology Oncology Center, Inc., Elyria
Park Nicollet Institute Dept. of Park Nicollet, Saint Louis Park
Hematology Oncology Centers of the Northern Rockies Hema Onc Ctr N. Rockies (4, Billings
St. John's Mercy Medical Center St. John's Mercy Med Ctr, St Louis
Southeast Nebraska Oncology Cancer Center, Lincoln
Hematology Oncology Services of Arkansas, Little Rock
Clopton Clinic, Jonesboro
Highlands Oncology Group, Fayetteville
East Texas Medical Center Cancer Institute Tyler Hem/Onc (3), Tyler
South Texas Oncology and Hematology, PA South Texas Oncology (2), San Antonio
Kootenai Medical Center Kootenai Medical Center, Coeur d'Alene
Reno Oncology Consultants, Reno
Wilshire Oncology Medical Group, La Verne
Loma Linda University Loma Linda Cancer Center, Loma Linda
Kaiser Permanente Medical Group Kaiser Permanente - Hawaii, Anaheim
Northwest Medical Specialties, Tacoma
Hematology and Medical Oncology, Waterbury
Oncology Specialists, SC Lutheran General Cancer Instit, Park Ridge
Cancer Center of Kansas, Witchita
Somerset Hematology Oncology Associates Somerset Hema Oncol Assoc (2), Somerset
Cooper Cancer Center, Voorhees Township
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY